{"id":4649,"date":"2026-09-03T20:45:00","date_gmt":"2026-09-03T20:45:00","guid":{"rendered":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/"},"modified":"2026-09-04T04:59:10","modified_gmt":"2026-09-04T04:59:10","slug":"utm_campaignrss-43","status":"publish","type":"post","link":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/","title":{"rendered":"FDA approves Zanvastro from Ionis, first drug for Alexander illness"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div>\n<p class=\"wp-block-paragraph\">Ionis Prescription drugs on Thursday acquired Meals and Drug Administration approval for the primary illness modifying remedy for Alexander illness, a uncommon and lethal neurological situation.<\/p>\n<p class=\"wp-block-paragraph\">The FDA accredited the drug, Zanvastro, to be used in kids and adults after a pivotal trial confirmed that strolling velocity, a typical measure of motor perform in neurologic illness, stayed steady in handled sufferers whereas these within the management group noticed a 33% decline.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">The research additionally contained hints that treating younger kids can enhance motor perform, not simply stabilize it. Researchers discovered that the drug was typically secure, with severe hostile occasions extra frequent within the management group than amongst these handled.<\/p>\n<div class=\"restricted-content-breaker article\" aria-labelledby=\"restricted-story-heading\" aria-describedby=\"restricted-story-description\" checked=\"false\">\n<div class=\"restricted-content-breaker-bar\">\n<p class=\"restricted-text\">STAT+ Unique Story<\/p>\n<p class=\"restricted-login\">Have already got an account? Log in<\/p>\n<\/p><\/div>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<div class=\"restricted-content-breaker-wrapper\">\n\t\t\t\t<span class=\"stat-paywall-archive\"><\/p>\n<p>\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t<\/span><\/p>\n<h2 id=\"restricted-story-heading\">This text is unique to STAT+ subscribers<\/h2>\n<h3 id=\"restricted-story-description\">Unlock this text \u2014 plus each day protection and evaluation of the biotech sector \u2014 by subscribing to STAT+.<\/h3>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Have already got an account? Log in<\/p>\n<div class=\"restricted-content-breaker-cards\">\n<div class=\"slider-container\" aria-label=\"Subscription plan toggle\">\n\t\t\t\t\t\tParticular person plans<\/p>\n<p>\t\t\t\t\t\tGroup plans\n\t\t\t\t\t<\/p><\/div><\/div>\n<p>\t\t\t\tView All Plans\n\t\t\t<\/p><\/div><\/div>\n<div class=\"restricted-message-breaker\">\n<div class=\"restricted-content-wrapper\">\n<div class=\"restricted-content-message\">\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo learn the remainder of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\tSubscribe\n\t\t\t\t\t\t\t\t\t<\/p><\/div><\/div><\/div><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.statnews.com\/2026\/09\/03\/ionis-fda-approval-zanvastro-alexander-disease\/?utm_campaign=rss\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ionis Prescription drugs on Thursday acquired Meals and Drug Administration approval for the primary illness modifying remedy for Alexander illness, a uncommon and lethal neurological situation. The FDA accredited the drug, Zanvastro, to be used in kids and adults after a pivotal trial confirmed that strolling velocity, a typical measure of motor perform in neurologic [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4651,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg","fifu_image_alt":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[10],"tags":[4790,2540,2065,497,813,4577,4789],"class_list":["post-4649","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","tag-alexander","tag-approves","tag-disease","tag-drug","tag-fda","tag-ionis","tag-zanvastro"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA approves Zanvastro from Ionis, first drug for Alexander illness - Future News 24<\/title>\n<meta name=\"description\" content=\"Ionis Pharmaceuticals receives FDA approval for Zanvastro, the first disease-modifying therapy for rare and fatal neurological Alexander disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves Zanvastro from Ionis, first drug for Alexander illness - Future News 24\" \/>\n<meta property=\"og:description\" content=\"Ionis Pharmaceuticals receives FDA approval for Zanvastro, the first disease-modifying therapy for rare and fatal neurological Alexander disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/\" \/>\n<meta property=\"og:site_name\" content=\"Future News 24\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-03T20:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-04T04:59:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg\" \/>\n<meta name=\"author\" content=\"Future News 24\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Future News 24\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/\"},\"author\":{\"name\":\"Future News 24\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\"},\"headline\":\"FDA approves Zanvastro from Ionis, first drug for Alexander illness\",\"datePublished\":\"2026-09-03T20:45:00+00:00\",\"dateModified\":\"2026-09-04T04:59:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/\"},\"wordCount\":183,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/AP7357695644179726-1024x576.jpg\",\"keywords\":[\"Alexander\",\"approves\",\"Disease\",\"drug\",\"FDA\",\"Ionis\",\"Zanvastro\"],\"articleSection\":[\"BioTechnology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/\",\"name\":\"FDA approves Zanvastro from Ionis, first drug for Alexander illness - Future News 24\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/AP7357695644179726-1024x576.jpg\",\"datePublished\":\"2026-09-03T20:45:00+00:00\",\"dateModified\":\"2026-09-04T04:59:10+00:00\",\"description\":\"Ionis Pharmaceuticals receives FDA approval for Zanvastro, the first disease-modifying therapy for rare and fatal neurological Alexander disease.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/AP7357695644179726-1024x576.jpg\",\"contentUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/AP7357695644179726-1024x576.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/09\\\/03\\\/utm_campaignrss-43\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/futurenews24.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves Zanvastro from Ionis, first drug for Alexander illness\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"name\":\"Future News 24\",\"description\":\"The Smart Hub for AI and Next-Gen Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/futurenews24.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\",\"name\":\"Future News 24\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"contentUrl\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"width\":250,\"height\":250,\"caption\":\"Future News 24\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\",\"name\":\"Future News 24\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"caption\":\"Future News 24\"},\"sameAs\":[\"https:\\\/\\\/futurenews24.com\"],\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/author\\\/mridulpahuja20\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA approves Zanvastro from Ionis, first drug for Alexander illness - Future News 24","description":"Ionis Pharmaceuticals receives FDA approval for Zanvastro, the first disease-modifying therapy for rare and fatal neurological Alexander disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/","og_locale":"en_US","og_type":"article","og_title":"FDA approves Zanvastro from Ionis, first drug for Alexander illness - Future News 24","og_description":"Ionis Pharmaceuticals receives FDA approval for Zanvastro, the first disease-modifying therapy for rare and fatal neurological Alexander disease.","og_url":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/","og_site_name":"Future News 24","article_published_time":"2026-09-03T20:45:00+00:00","article_modified_time":"2026-09-04T04:59:10+00:00","og_image":[{"url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg","type":"","width":"","height":""}],"author":"Future News 24","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg","twitter_misc":{"Written by":"Future News 24","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/#article","isPartOf":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/"},"author":{"name":"Future News 24","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83"},"headline":"FDA approves Zanvastro from Ionis, first drug for Alexander illness","datePublished":"2026-09-03T20:45:00+00:00","dateModified":"2026-09-04T04:59:10+00:00","mainEntityOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/"},"wordCount":183,"commentCount":0,"publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg","keywords":["Alexander","approves","Disease","drug","FDA","Ionis","Zanvastro"],"articleSection":["BioTechnology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/","url":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/","name":"FDA approves Zanvastro from Ionis, first drug for Alexander illness - Future News 24","isPartOf":{"@id":"https:\/\/futurenews24.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/#primaryimage"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg","datePublished":"2026-09-03T20:45:00+00:00","dateModified":"2026-09-04T04:59:10+00:00","description":"Ionis Pharmaceuticals receives FDA approval for Zanvastro, the first disease-modifying therapy for rare and fatal neurological Alexander disease.","breadcrumb":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/#primaryimage","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/09\/AP7357695644179726-1024x576.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/futurenews24.com\/index.php\/2026\/09\/03\/utm_campaignrss-43\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/futurenews24.com\/"},{"@type":"ListItem","position":2,"name":"FDA approves Zanvastro from Ionis, first drug for Alexander illness"}]},{"@type":"WebSite","@id":"https:\/\/futurenews24.com\/#website","url":"https:\/\/futurenews24.com\/","name":"Future News 24","description":"The Smart Hub for AI and Next-Gen Innovation","publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurenews24.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/futurenews24.com\/#organization","name":"Future News 24","url":"https:\/\/futurenews24.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/","url":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","contentUrl":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","width":250,"height":250,"caption":"Future News 24"},"image":{"@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83","name":"Future News 24","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","caption":"Future News 24"},"sameAs":["https:\/\/futurenews24.com"],"url":"https:\/\/futurenews24.com\/index.php\/author\/mridulpahuja20\/"}]}},"_links":{"self":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/comments?post=4649"}],"version-history":[{"count":1,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4649\/revisions"}],"predecessor-version":[{"id":4650,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4649\/revisions\/4650"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media\/4651"}],"wp:attachment":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media?parent=4649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/categories?post=4649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/tags?post=4649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}